ImpediMed Limited

IPD

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. The company is headquartered in Brisbane, Queensland and currently employs 76 full-time employees. The company went IPO on 2007-10-24. The firm uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The firm designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. SOZO uses its BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.

Ipd Group Ltd

IPG

IPD Group Ltd. engages in the servicing industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-12-17. The firm's Products division is engaged in the sale of electrical infrastructure products to customers, including switchboard manufacturers, electrical wholesalers, electrical contractors, power utilities, original equipment manufacturers (OEMs) and system integrators. Within the division there are five categories of products: power distribution, industrial and motor control, automation and industrial communication, power monitoring, and hazardous area equipment. In addition to selling products, it provides a range of value-added services, including custom assembly, sourcing, engineering design, technical compliance, procurement, transport, storage, regulatory management, technical support, packaging, labelling, inventory management and delivery. Its Services division is engaged in provision of services, including installation and commissioning, calibration and testing, maintenance, and repairs, and others.

BetaShares Future of Payments ETF

IPAY

IPAY.AX was created on 2021-12-13 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. IPAY.AX aims to track the performance of an Index (before fees and expenses) that provides exposure to a

IPB Petroleum Limited

IPB

IPB Petroleum Ltd. is an oil and gas exploration company, which holds interest in the WA-424-P exploration permit project. The company is headquartered in Melbourne, Victoria. The company went IPO on 2013-04-30. The firm has a 100% interest in the petroleum exploration permits located in the Browse Basin: WA-424-P. The Browse Basin is located north of Broome, offshore, Western Australia, and covers an area of approximately 140,000 square kilometers (km2). The WA-424-P permit contains three wells, including Gwydion-1, Caspar-1A and Pryderi-1. The Company’s subsidiaries include IPB WA 424P Pty Ltd and IPB Exploration Pty Ltd.